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S100 Ca +-binding proteins have been associated with a multitude of intracellular Ca +-
dependent functions including regulation of the cell cycle, cell differentiation, cell motility
and apoptosis, modulation of membrane–cytoskeletal interactions, transduction of intra-
cellular Ca2+ signals, and in mediating learning and memory. S100 proteins are ﬁne tuned
to read the intracellular free Ca2+ concentration and affect protein phosphorylation, which
makes them candidates to modulate certain ion channels and neuronal electrical behav-
ior. Certain S100s are secreted from cells and are found in extracellular ﬂuids where they
exert unique extracellular functions. In addition to their neurotrophic activity, some S100
proteins modulate neuronal electrical discharge activity and appear to act directly on ion
channels.The ﬁrst reports regarding these effects suggested S100-mediated alterations in
Ca2+ ﬂuxes, K+ currents, and neuronal discharge activity. Recent reports revealed direct
and indirect interactions with Ca2+, K+, Cl−, and ligand activated channels. This review
focuses on studies of the physical and functional interactions of S100 proteins and ion
channels.
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ION CHANNELS
Ion channel proteins form hydrophilic pores integrated into lipid
bilayer membranes allowing the passage of ions into and out of
cells. Channels are incorporated not only in the plasma mem-
brane, but also inmembranes of intracellular organelles, including
the endoplasmic reticulum, nuclear membrane, and mitochon-
dria. Ion channels are found early in the evolution of life and are
essential for the function of cells in every organism from bacteria,
protozoa, and plants, to animals. Their functions range from the
Abbreviations: 5-HT, serotonin receptor; AMPA, α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor; ASIC, acid-sensing ion channels; BK, big or large
conductance calcium activated K+ channels; Ca2+, calcium ion; CaBP, calcium
binding protein; cAMP/PKA/CnA, cyclic adenosine monophosphate/protein kinase
A/calcineurin A – protein phosphatase; CFTR, cystic ﬁbrosis transmembrane con-
ductance; cGMP, cyclic guanosine monophosphate; C-terminal, carboxy terminus
of proteins; Cl−, chloride ion; D3–D4, linker between domains 3 and 4 (channel);
EF-hand, helix-loop-helix structural motif of calcium binding proteins; EK, potas-
sium equilibrium potential; hEAG, human ether a go–go K+ channel; IK, calcium
activated intermediate conductance K+ channels; IQ motif, proteins that contain IQ
motifs typically bind calmodulin in the absence of Ca2+; K+, potassium ion; K2P,
two-pore domain K+ channel; Kir, inward rectiﬁer K+ channel; Kv, voltage gated
K+ channel; KRR, lysine– arginine–arginine; L-type Ca2+ channel, voltage gated
Ca2+ channel with large conductance and long-lasting activation; MAPK, mitogen-
activated protein kinase; Mn2+, manganese ion; Na+, sodium ion; Nav, voltage
gated Na+ channel; NMDA, N -methyl-d-aspartate; N-terminal, amino-terminus
of proteins; p11, S100A10 protein; PKA, protein kinase A; pS, piko Siemens; RAGE,
receptor for advanced glycation end products; ROS-GC, rod outer segment guany-
late cyclase; RyR, ryanodine receptor; S100, protein soluble in 100% ammonium
sulfate; S100B-s-s, disulﬁde linked form of S100B; S1–S6 TMS, transmembrane
segments 1–6 (channel); SCG, superior cervical ganglion; SK, small conductance
calcium activated K+ channels; SR, sarcoplasmatic reticulum; SSV, serine–serine–
valine; TASK, TWIK-related Acid Sensitive K+ channel; TMS, transmembrane
segments; T-tubulus, transverse tubulus (muscle); TRP, transient receptor potential;
TTX, tetrodotoxin; Zn2+, zinc ion.
modulation of bioelectric processes, such as sensory transduction,
action potential generation and propagation, and synaptic trans-
mission, to muscle contraction and osmoregulation, control of
hormone release, and cell cycle coordination (e.g., in Hille, 2001;
Weiger et al., 2002). Many ion channels are highly selective for a
certain type of ion, such as K+, Na+, Ca2+, or Cl−; others, like
NMDA or AMPA receptors, are less selective and allow different
cations to pass. An element known as the selectivity ﬁlter within
the channel pore is the critical determinant of what type of ions
can be transmitted by a channel.
Conformational changes between closed, open, and inactive
states are termed channel gating. Since there are many channels
within a membrane, the equilibrium between these conforma-
tional states determines the amount of current that ﬂows across
the membrane as a function of time. Importantly, channel gating
is initiated by: (i) changes of the voltage across the membrane, (ii)
binding of ligands such as neurotransmitters, hormones, intracel-
lular messengers (e.g., Ca2+, cyclic nucleotides), (iii) mechanical
stress to the protein or via the cytoskeleton linked to channels, or
(iv) covalent modiﬁcations such as protein phosphorylation, car-
boxylation, or sulfuration (Levitan, 1999; Hermann et al., 2012).
Ion channels can be blocked by chemical agents or by peptide
toxins, which can be used for separation of ion currents or for
identiﬁcation of certain types of channels. Modiﬁcations to chan-
nel gating function can occur across a large range of timescales
from milliseconds to hours or even days. Long-term changes of
the electrical excitability of neurons may be considered as a kind
of cellular memory.
Mutations at ion channels are involved in causing a number of
diseases, including diabetes, epilepsy, heart failure, myotonia, and
deafness (Shieh et al., 2000; Ashcroft, 2006; Bernard and Shevell,
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2008; Kullmann, 2010). Patch clamp techniques have proven as
powerful means to study ion channels in action. Together with
molecular biology techniques, in particular site-directed muta-
genesis, it has become possible to investigate intimate details
of channel structure and function, and the molecular basis for
channel-associated diseases.
A number of ion channels are activated or modulated by intra-
cellular Ca2+ signals giving rise to the notion that Ca2+ binding
proteins (CaBP) may play a role in regulating channel gating func-
tion. For example, CaBPs have been found to modulate neuronal
electrical discharge activity (Celio, 1986; Kawaguchi et al., 1987;
Barger and van Eldik, 1992; Hermann and Kerschbaum, 1994;
Kubista et al., 1999; Burgoyne and Weiss, 2001; Schwaller, 2010).
These effects are based on either alterations of intracellular Ca2+,
which secondarily affects ion channels, transmitter release, and
activation of second messengers, or on direct action of a CaBP
on ion channels (i.e., in Neher and Sakaba, 2008; Nejatbakhsh
and Feng, 2011). Some K+, Na+, and Cl− channels are regulated
directly by intracellular Ca2+. Among these, Ca2+-activated K+
channels are prominent in this respect, as they are found in a wide
variety of excitable and non-excitable cells and in many species.
The most prominent of these CaBPs is the ubiquitous intracellular
Ca2+ sensor calmodulin. Ca2+-dependent regulation of ion chan-
nels was reviewed 6 years ago (Shah et al., 2006a). Here, we focus
on the relatively recent and growing evidence for roles played by
the S100 proteins.
S100 CALCIUM BINDING PROTEINS
S100 proteins are a group of >20 EF-hand Ca2+-binding proteins
that are distinguished by several unique characteristics including
expression in a cell-speciﬁcmanner and functions in both intracel-
lular and extracellular contexts (Donato, 2001; Heizmann, 2002;
Chazin, 2011). The proteins appear to be exclusively expressed in
vertebrates on the basis of genomic analyses, which points to spe-
cialized roles evolved late in evolution. These roles are believed
to involve the reﬁnement or ﬁne tuning of cell-speciﬁc activities
and/or responses. Of the 24 human S100 genes, 19, plus a num-
ber of S100A pseudogenes are located within chromosome 1q21.
Other gene locations include S100A11P, which maps to chromo-
some 7q22-q3, S100B, which maps to chromosome 21q22, S100G,
which maps to chromosome Xp22, S100P, which maps to chro-
mosome 4p16, and S100Z, which maps to chromosome 5q13
(Marenholz et al., 2004). S100 proteins are distinguished from
other EF-hand proteins by the unique manner in which they bind
Ca2+ ions in their N-terminal binding sites, a distinctive dimeric
architecture, and the ability to bind transition metals such as zinc,
copper, and manganese at histidine-rich binding sites at the dimer
interface. The large number of atomic resolution structures deter-
mined for S100 proteins reveal a very common structure. Thus,
they can be best classiﬁed on the basis of their functional roles (for
overview of structure and function of S100 proteins see Donato,
2001, 2003; Heizmann, 2002; Chazin, 2011).
S100 proteins regulate a diverse array of cellular activities,
including the cell cycle (Arcuri et al., 2005; Brozzi et al., 2009),
cell differentiation and survival (Arcuri et al., 2005; Tsoporis et al.,
2005; Rosenberger et al., 2007; Cheng et al., 2008; Tubaro et al.,
2010; Beccaﬁco et al., 2011; Liu et al., 2011; Riuzzi et al., 2011),
apoptosis (van Dieck et al., 2009; Lin et al., 2010; Tubaro et
al., 2011), cell motility (Brozzi et al., 2009; Chen et al., 2009),
membrane–cytoskeleton interactions and cytoskeleton dynamics
(Donato, 2001; Brozzi et al., 2009), intracellular Ca2+ homeostasis
(Donato et al., 2009; Rohde et al., 2010), transduction of intracel-
lular Ca2+ signals (Donato, 2001; Heizmann, 2002; Gilquin et al.,
2010), learning and memory (Nishiyama et al., 2002), phototrans-
duction (Pozdnyakov et al., 1997; Rambotti et al., 1999; Duda
et al., 2002), adaptive responses to antidepressants (Svennings-
son and Greengard, 2007; Rescher and Gerke, 2008; Baudry et al.,
2010), and innate and adaptive immunity (Donato, 2001; Heiz-
mann,2002; Bode et al., 2008). They are also associatedwith awide
array of pathological conditions such as inﬂammation (Donato,
2001, 2007; Heizmann, 2002; Vogl et al., 2007; Cheng et al., 2008;
Donato et al., 2009; Ehrchen et al., 2009;Hsu et al., 2009;Hofmann
Bowman et al., 2010; Lim et al., 2010, 2011;Wolf et al., 2011a), can-
cer (Donato, 2001, 2007; Heizmann, 2002; Emberley et al., 2005;
Stein et al., 2006; Ismail et al., 2008; Chen et al., 2009; Donato et al.,
2009; Slomnicki et al., 2009; van Dieck et al., 2009; Lin et al., 2010;
Malashkevich et al., 2010;Wolf et al., 2011b), diabetes and its com-
plications (Eggers et al., 2011), atherosclerosis (Averill et al., 2011),
mood and personality disorders (Steiner et al., 2010, 2011), and
neurodegeneration (Donato, 2001, 2007;Heizmann,2002;Donato
et al., 2009; Sorci et al., 2010).
Most S100 proteins exert intracellular regulatory activities by
interacting with speciﬁc target sites in a Ca2+-dependent manner
(Donato, 2003; Bhattacharya et al., 2004; Donato et al., 2009; Zim-
mer and Weber, 2010). At low internal Ca2+ concentration, as in
the resting state of cells, S100 proteins occupy a closed relatively
hydrophilic conformation. During cell activation the intracellu-
lar Ca2+ concentration increases due to Ca2+ inﬂux via plasma
membrane Ca2+ channels or liberation from intracellular Ca2+
stores such as the endoplasmic or sarcoplasmatic reticulum (SR).
S100 proteins have afﬁnites for Ca2+ in a range that allows them
to respond to these higher Ca2+ concentrations (with one excep-
tion of S100A10, which is Ca2+ insensitive). Binding of Ca2+ to
S100s exposes hydrophobic sites, which enable them to interact
with speciﬁc target proteins or membranes (Bhattacharya et al.,
2004). A great variety of targets have been identiﬁed over the years,
including enzymes, cytoskeletal constituents, transcription factors,
scaffolding proteins, unsaturated fatty acids, channels, receptors,
signaling molecules, and toll-like receptor ligands (Donato, 2003;
Sorci et al., 2011). Thus, S100 proteins are extremely versatile and
are able to perform functions in an array of cellular pathways.
Some S100 proteins can be secreted andhave the potential to act
on the external surface of plasma membranes. In contrast to intra-
cellular function, extracellular S100 proteins will have all Ca2+
binding sites occupied so the molecular basis for their function is
dependent on other properties, including their ability to oligomer-
ize or to bind transition metals such as Zn2+ and Mn2+. Due to
their hydrophobic nature in the Ca2+ loaded state, it is possible
that S100 proteins may directly interact with the lipid phase of the
membrane (Curatola et al., 1985; Zolese et al., 1988) and pertur-
bation of membrane lipids may affect membrane channel activity.
Direct interactions of S100G with phospholipids have been been
characterized (Malmendal et al., 2005). S100 proteins could also
act at the extracellular face onmembrane localized proteins such as
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receptors or ion channels. One such receptor is RAGE (receptor for
advanced glycation end products), which is found in inﬂamed tis-
sue and in several human cancers. RAGEbinds and signals through
a number of S100 proteins, including S100A1, S100A2, S100A5,
S100A6, S100A7, S100A8/A9, S100A11, S100A12, S100A13, S100B,
andS100P in ahighnumberof cell types (Donato,2007;Heizmann
et al., 2007; Ghavami et al., 2008; Leclerc et al., 2009; Beccaﬁco
et al., 2011; Eggers et al., 2011). In addition, G-protein-coupled
receptors, scavenger receptors, and toll-like receptor 4 transduce
effects of certain S100 proteins (Vogl et al., 2007; Yan et al., 2008;
Pietzsch and Hoppmann, 2009; Hoppmann et al., 2010). Lastly,
S100A4 and S100B interact with epidermal growth factor ligands
and basic ﬁbroblast growth factor, respectively (Klingelhöfer et al.,
2009; Riuzzi et al., 2011, 2012) thereby enhancing cognate recep-
tor activity. External binding of S100 proteins to ion channels has,
however, not been reported so far.
S100 PROTEINS AND MODULATION OF ION CHANNELS
The ﬁrst reports relating to an S100 protein (likely S100B) mod-
ulating channel activity involved affects on discharge activity in
mollusk neurons (Shtark et al., 1981;Nikitin et al., 1988). In partic-
ular, anti-S100 antiserum was found to inhibit electrical activity of
these neurons and caused a reduction of both inward and outward
currents (Pozdnyakova, 1988; Andrianov et al., 2003; Gainutdinov
et al., 2006;Timoshenko et al., 2009). From these studies itwas con-
cluded that the S100-antigen is accessible to S100 antibodies and
therefore is localized at the plasma membrane. S100 immunore-
activity was also found in protozoa, earthworms, crustacean, and
insects (Michetti and Cocchia, 1982; Endo and Endo, 1988). In the
snail (Helix pomatia) central nervous system, an S100 immunore-
active protein of 12–14 kDa, as revealed by Western blot analysis,
was localized in a subpopulation of neurons (Kubista et al., 1996).
Theseneurons are speciﬁedby their spontaneousdischarge activity
and a prominent Ca2+-activated K+ outward current (Hermann
et al., 1995). S100 immunoreactivity was present in neurons, but
not in glial cells, endocrine cells, or in muscle, and its presence
was correlated with spontaneous discharge activity of these cells.
Extracellular S100B-s-s, a disulﬁde linked form of S100B, which
is secreted and/or released from several mammalian cells (Donato
et al., 2009) in nanogram quantities caused hyperpolarization of
the membrane resting potential and inhibition of the spontaneous
discharge activity of action potentials (Kubista et al., 1999). Fur-
thermore, the stimulus–response property of neurons was found
to be altered from tonic to phasic discharge, the duration of action
potentials was decreased, their after hypolarization increased, and
the membrane input resistance reduced. Voltage clamp experi-
ments revealed that the total outward current was increased by
S100B-s-s-. Detailed analysis of outward currents showed that
three types of K+ currents were altered: the inward rectifying
current was increased by S100B-s-s- as was the Ca2+-activated
K+ outward current, whereas the delayed, voltage-dependent K+
current was decreased. The transient K+ outward current and
the Ca2+ inward current also present in these neurons were not
affected by S100B-s-s-. Immunocytochemistry revealed that after
extracellular application of S100B-s-s-, intracellular labeling of
the cytoplasm revealed internalization. Injection of S100A1 mim-
icked the effects of S100B-s-s- on discharge activity and action
potentials. From these experiments it was concluded that S100
may play a role as neuromodulator in nervous functions (Kubista
et al., 1999). Although evidence is still missing that S100 proteins
are present in invertebrates there are clear effects on electrical
activity, which indicates that channel proteins interact with S100
and alter their conductive properties.
S100s AND Ca2+ CHANNELS
Recently, ion channels have been recognized as potential targets
for S100 proteins. S100A1, for example, increases the L-type Ca2+
channel current in embryonic mouse and neonatal rat ventricular
cardiomyocytes. Because protein kinase A (PKA) block abolished
the S100A1 effect onCa2+ channels it was concluded that a S100A1
mediated increase of PKA enhances Ca2+ inﬂux (Reppel et al.,
2005). Chronic deﬁciency of S100A1 in knock-out mice results
in an elevated Ca2+ inward current but a blunted β-adrenergic
response due to an impaired fractional Ca2+ release mechanism
from intracellular stores (Gusev et al., 2009).
S100A10, also known as p11 or calpactinI light chain, is “Ca2+
insensitive” because of mutations within the Ca2+ binding loops
of its EF-hands. The S100A10 molecular structure is equivalent
to the Ca2+ bound forms of other S100 proteins with exposed
hydrophobic sites which render the protein in a permanently
active state. The protein associates with annexin 2 into a het-
erotetrameric complex and hence is able to speciﬁcally target
membranes (Gerke and Moss, 2002; Rescher and Gerke, 2008).
Ca2+ binding to annexin 2 (a phospholipid and Ca2+ binding
protein) allows for interaction with membranes. Thus, S100A10-
annexin 2 can link proteins to membranes or attach to and
modulate other proteins. Interestingly, the protein predominantly
binds to the plasma membrane where it interacts for example with
phosphatidylinositol-bisphosphate (PI(4,5)P2) or cholesterol-rich
domains (Rescher et al., 2004). S100A10-annexin 2 has been iden-
tiﬁed as auxiliary protein in epithelial Ca2+ permeant TRPV5
and TRPV6 channels (van de Graaf et al., 2003). TRP (transient
receptor potential) channels constitute a superfamily of sensory
channels whose functions range from phototransduction (where
they were ﬁrst described), olfaction, heat, cold sensation, etc., to
Ca2+ sensors/transporters. The TRP Ca2+ channels are important
for absorption of Ca2+ into kidney, placenta, or intestine to main-
tain systemic Ca2+ homeostasis. The S100A10-annexin 2 complex
speciﬁcally associates with the C-terminal of TRP channels and is
suggested to play a role in guiding and localizing channels to the
plasma membrane and/or in the modulation of channel activity.
The later has been shown by using annexin 2 interfering RNA,
which inhibited currents through TRP channels (van de Graaf
et al., 2003). S100A10-annexin 2 is also involved in nociceptive
function. It appears to act as scaffolding protein that conjugates
appropriate proteins at the plasma membrane. Deletion of the
proteins exclusively from nociceptive sensory neurons in mice was
attended by a loss of TTX-resistant Na+ (Nav1.8) channels and
compromised neuropathic pain behavior (Foulkes et al., 2006).
S100A10-annexin 2 also interacts with acid-sensing ion chan-
nels (ASIC1a; Donier et al., 2005). Coexpression of S100A10-
annexin 2 and the ASIC1a channels led to an increased expres-
sion of ion channels at the plasma membrane and a concom-
mitant increase of the peak current. Since no other parameters
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were affected it was suggested that the primary role of S100A10-
annexin 2 is to enhance the expression of the acid-sensing chan-
nels in the plasma membrane, which supports the notion of
S100A10-annexin 2 functioning as trafﬁcking device.
S100B and likely S100A1 interact with and stimulate rod outer
segment andphotoreceptor bipolar cell synapsemembrane guany-
late cyclase (ROS-GC1), which is a bimodal Ca2+ signal transduc-
tion switch that increases its rate of cyclic GMP synthesis when
intracellular Ca2+ rises to high levels and when Ca2+ falls to
very low levels (Pozdnyakov et al., 1997; Rambotti et al., 1999;
Duda et al., 2002). S100B and likely S100A1 stimulate photore-
ceptor ROS-GC1 activity as Ca2+ approaches micromolar levels,
i.e., when photoreceptors are dark adapted, implying that S100B
and likely S100A1 are important in dark adaptation. Thus, S100B
and S100A1 indirectly regulate a photoreceptor Ca2+ channel via
stimulation of ROS-GC1. However, S100B and S100A1 also acti-
vate a membrane bound guanylate cyclase in retinal Müller cells
(Rambotti et al., 1999), and S100B stimulates a membrane bound
guanylate cyclase in thephotoreceptor bipolar synapse (Duda et al.,
2002), which suggests that at those sites also at least S100B might
indirectly regulate Ca2+ ﬂux via activation of a membrane bound
guanylate cyclase.
S100A1 and S100B each promote Ca2+ ﬂux across artiﬁcial
membranes (Garbuglia et al., 2000) as do annexins 5 and 6 (Gerke
and Moss, 2002). S100A1 and S100B interact with annexins 5 and
6 which results in reduced ability of these two annexins and of
S100A1 and S100B to stimulate Ca2+ ﬂux across artiﬁcial mem-
branes likely via reciprocal sequestration within the cytoplasm
(Garbuglia et al., 2000). These four proteins are located close
to or on skeletal muscle membrane structures such as the sar-
colemma, the sarcoplasmic reticulum, and T-tubules (Arcuri et al.,
2002) that are critically involved in the regulation of Ca2+ ﬂuxes.
This suggests that S100A1 and S100B might modulate the pro-
posed Ca2+ channel activity of annexins 5 and 6 and/or annexin
6-dependent regulation of Ca2+ release from the sarcoplasmic
reticulum (Díaz-Muñoz et al., 1990).
Signaling via ion channels appears to be also involved in regula-
tion of S100B secretion.Hippocampal brain slices in the absence of
extracellularCa2+ or lowK+ caused an increase of S100B secretion
(probably by internal Ca2+ liberation which is a common mecha-
nism in glial cells), whereas high extracellular K+ or Ca2+ channel
blockers had the opposite effect (Nardin et al., 2009). This may
be relevant during/after neuronal activity, particularly after exces-
sive excitation such as in epileptic seizure, where within a small
interstitial volume around cells ion concentrations may change
signiﬁcantly.
S100A1 binds to ryanodine receptors at nanomolar Ca2+ con-
centrations and enhances Ca2+ release in skeletal and in cardiac
muscle (Treves et al., 1997; Prosser et al., 2008;Wright et al., 2008).
Ryanodine receptors are L-type Ca2+ channels located in the SR,
which after opening allow Ca2+ ions to ﬂow down their elec-
trochemical gradient from the higher concentration with the SR
to the lower concentrated cytoplasm. S100A1 increased the open
probability of the ryanodine Ca2+channels reconstituted into pla-
nar lipid bilayers (Treves et al., 1997). S100A1, after binding of
Ca2+ exposes hydrophobic pockets and competes with calmod-
ulin for the same binding site, which is conserved in striated
muscle (Schäfer and Heizmann, 1996). S100A1 knock-out mice
exhibit decreased actionpotential evokedCa2+ release via SR ryan-
odine receptors (Prosser et al., 2010). From these experiments it
appears that intracellular S100A1 regulates Ca2+ channels that
subsequently promote muscle contractility. The authors further
examined the effect of S100A1 on the voltage sensor of excitation–
contraction coupling (Prosser et al., 2009a,b). Depolarization of
the transverse (T) tubulus system by action potentials that spread
over the muscle sarcolemma acts at the voltage sensor of the ruthe-
nium/calcium receptor/channel. The conformational changes of
the protein mechanically transmit to dihydropyridine receptors,
which are also L-type Ca2+ channels, located in the SR mem-
brane. Charge movement within these channels is responsible for
opening and release of Ca2+ from the SR. Part of the charge move-
ment, the so called “delayed charge movement” (termed Qgamma),
is selectively suppressed in S100A1 knock-out muscle ﬁbers. Both,
skeletal and cardiac ryanodine receptors are regulated this way
by S100A1. The Qgamma component activated by S100A1, how-
ever, appears not to be linked to gating of dihydropyridine Ca2+
channels, but is more likely involved in the excitation–contraction
coupling machinery (Prosser et al., 2009a). S100A1 also improves
Ca2+ cycling and contractility in cardiac muscle (Most et al., 2007)
and increased Ca2+ release and force of contraction in skinned
muscle ﬁbers (Most et al., 2003).
Cardiomyocytes secrete S100A1 during ischemia which is taken
up by superior cervical ganglion (SCG) neurons (which do not
contain the protein) and distribute the protein intracellularly
via axonal transport (Hernández-Ochoa et al., 2009). Extra- or
intracellularly applied S100A1 enhanced voltage activated Ca2+
channels dependent on PKA activity, prolonged action potentials,
and augmented transient cytosolic Ca2+ increase. S100A1 was
shown to directly interact with PKA and this complex appears to
affectCa2+ channels. S100A1 therefore appears to act as a signaling
molecule that increases sympathetic output.
S100s AND K+ CHANNELS
K+ channels are the most abundant and versatile kind of channel
ubiquitously present in cells. K+ channels once activated allow
K+ ions to move down their electrochemical gradient, which is
usually from inside (high concentration and negative membrane
potential) to the external side of the plasma membrane. Since
the equilibrium potential (EK) for K+ is negative (EK∼−60 to
−90mV in nerve and glial cells), opening of K+ channels drives
themembrane potential toward the equilibrium for K+ and causes
hyperpolarization of cells. K+ channels are therefore involved in
establishing and maintenance of the membrane resting potential,
in repolarization of action potentials, or in membrane potential
oscillations. In essence K+ channels provide a negative feedback
to adjust the excitability of cells.
The many types of K+ channels are classiﬁed into three major
families depending on their number of transmembrane seg-
ments/helices (TMS). Formation of a functional channel involves
the assembly of two to four units, depending on the number of
TMSs in each family. The simplest K+ channel is the four times
two helix set, each containing a pore loop (P) and together form-
ing the channel – the so called “inward rectiﬁer,” Kir (2TMS/1P)
channel. Doubling of this basic structure yields four helices each
Frontiers in Pharmacology | Neuropharmacology April 2012 | Volume 3 | Article 67 | 4
Hermann et al. S100 – ion channels
containing two pore loops. Dimerization in the membrane pro-
vides four pore loops which form a channel – the so called “two-
pore domain K+ channels” (K2P or 4TMS/2P). These channels
are highly sensitive and modulated by external pH, by neuro-
transmitters and hormones and are a target of volatile anesthet-
ics (review Lotshaw, 2007; Mathie et al., 2010). These types of
channels contribute to the membrane resting potential and are
involved in modulating electrical activity of cells. The “voltage-
dependent K+ channels” consist of 6 TMS containing 1 pore loop
(6TMS/1P) each and on tetramerisation in the membrane assem-
ble to one K+ channel (Armstrong, 2003). A variation of this
channel type has 7 transmembrane segments (7-TMS) and a long
C-terminus that provides binding of Ca2+ ions – these channels
therefore have been termed “Ca2+ activated K+ channels” (for
recent reviews see Berkefeld et al., 2010; Lee and Cui, 2010; Wu
et al., 2010).
Ca2+ activated K+ channels are divided into three subfam-
ilies mainly deﬁned by their biophysical and pharmacological
properties. (a) Three types of “small K or SK channels” identi-
ﬁed have a single channel conductance (γ) of ∼10 pS, are voltage
independent, associated with the EF-hand Ca2+-binding protein
calmodulin, activated by Ca2+ binding to calmodulin, and some
are speciﬁcally blocked by the bee toxin apamin. (b)“Intermediate
K or IK channels,” which have a γ of 20–80 pS, are constitutively
associated with calmodulin, which is bound to the C-terminal
of the protein and confers Ca2+ sensitivity to the channels. These
channels have no or onlyweak voltage dependence and are blocked
by charybdotoxin (from scorpion) but are resistant to blockade
by apamin or iberiotoxin (scorpion toxin). (c) “Big (large or
maxi) conductance K+ channels (big K, BK)” with a γ of 100–
300 pS are activated by Ca2+/Mg2+ ions and membrane voltage
synergistically. These channels are speciﬁcally blocked by iberi-
otoxin and modulated by a great variety of compounds such as
ethanol, polyamines, or gasotransmitters (Weiger and Hermann,
1994, 2009; Jakab et al., 1997; Hermann et al., 2012). The various
types of SK, IK, or BK channels can be expressed alone or in com-
bination in many cells and tissues, as in the nervous or the vascular
system. These types of K+ channels are involved in action poten-
tial repolarization, modulation of action potential frequency, or
oscillatory electrical discharge activity.
In some Ca2+ activated K+ channels calmodulin exerts impor-
tant functions as Ca2+ sensor at the internal side as outlined above.
Since certain S100 proteins are able to compete with calmodulin
(Schäfer and Heizmann, 1996), this allows them to interact with
ion channels via this pathway. Ca2+ activated BK channels typi-
cally contain Ca2+ binding sites (of non EF-hand type) at their
C-terminal end. There is some indication that Ca2+ activated K+
conductance of invertebrate neurons is increased by S100 proteins
(Kubista et al., 1999). It should be noted that various S100 proteins
(A1, A6, A8, A9, A10, A13, and B) are enriched in cochlea, which
also expresses BK channels (Pyott et al., 2007). S100 proteins have,
however, not been yet reported being involved in activation or
modulation of these channels.
In Alzheimer’s disease a correlation between a loss of inward
rectiﬁer K+ channels (Kir4.1), BK channels, water channels (aqua-
porin 4), and a gain of S100B-positive astrocytes was found
(Wilcock et al., 2009). This has been attributed to a loss of a
common anchoring protein. Efﬂux of K+ ions via BK channels
at the astrocyte end feet results in vasodilation, which suggests an
important function of these channels in maintainance of vascu-
lar tone (Filosa et al., 2006). The correlation to S100B, however,
remains elusive.
S100A10-annexin 2 interacts speciﬁcally with one of the two-
pore domain K+ channels (K2P) – termed “TASK-1 channels”
(Girard et al., 2002). TASK channels (TWIK-related Acid Sensitive
K+ channels) are characterized by the absence of activation and
inactivation kinetics, hence are voltage independent and there-
fore are referred to as leak or background conductances involved
in setting the membrane resting potential. The channels sense
externalH+ around the physiological pH and are inhibited by hor-
mones and neurotransmitters (Lotshaw, 2007). The association
with S100A10-annexin 2 is essential for TASK-1 channel trafﬁck-
ing to the plasma membrane and hence for functionality. The
authors found that association requires the presence of a serine–
serine–valine (SSV) amino acid sequence in the C-terminus of
the channel. Another sequence – lysine–arginine–arginine (KRR)
just upstream of the SSV sequence – appeared as retention sig-
nal which makes TASK channels to reside within the endoplasmic
reticulum. It has been suggested that only after camouﬂaging the
KRR sequence by binding of S100A10-annexin 2 the channels can
move to the plasma membrane (Girard et al., 2002).
S100A10-annexin 2 also regulates trafﬁcking of the TTX-
resistant Na+ channels to the plasma membrane. However, these
channels do neither contain a SSV terminal sequence nor a KRR
motif but appear to exhibit similar motifs. Using different tech-
niques other authors found that S100A10-annexin 2 is localized to
amore distant site to theC-terminal end of TASK-1 and binding of
S100A10-annexin 2 to TASK-1 may represent the retention factor
that causes channels to remain in the ER hence retarding plasma
membrane expression of the channels (Renigunta et al., 2006).
S100B inhibits voltage-dependent and Ca2+ sensitive human
ether a go–go (hEAG1) K+ channels – a S1–S6 TMS contain-
ing 1 pore loop (6TMS/1P) type channel (Sahoo et al., 2010).
These K+ channels are ubiquitously expressed in neuronal tissue
and appear to play a role in tumor proliferation and progression.
When applied to the internal face of inside-out patches, S100B
caused a Ca2+-dependent block of the channels. S100B was fur-
ther shown to share the same binding sites with calmodulin and
hence was suggested to function as an alternative Ca2+ sensor for
these channels (Sahoo et al., 2010).
S100s AND Cl− CHANNELS
Cl− channels are found in various non-excitable cells, being
involved in volume and pH regulation, cell proliferation, or Ca2+
signaling (Suzuki et al., 2006). Cl− channels contain 10 or 12
transmembrane helices but bear no resemblance to cation chan-
nels. Functionally, these channels are involved in setting the resting
membrane potential of skeletal muscle, in solute transport, in pH
and volume regulation, in cell migration, cell proliferation, and
differentiation. The S100A10-annexin 2 complex was reported
to directly or indirectly activate mechano-/volume-sensitive Cl−
channels in endothelial cells (Nilius et al., 1996). S100A10-annexin
2 also relates to the functioning of the cystic ﬁbrosis trans-
membrane conductance (CFTR) under normal and pathologic
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Table 1 | Interactions of S100 proteins with ion channels1.
S100 protein Ion channel Other
channels
receptors
Reference
Na+ K+ Ca2+ Cl−
S100A1 heart, T-type Reppel et al. (2005)
in rods Pozdnyakov et al. (1997), Rambotti et al. (1999), Duda et al.
(2002)
Art. memb. Garbuglia et al. (2000), Arcuri et al. (2002)
SR Díaz-Muñoz et al. (1990), Treves et al. (1997)
RyR/L-type Prosser et al. (2008, 2010), Wright et al. (2008), Most et al.
(2003)
in neurons (SCG) Hernández-Ochoa et al. (2009)
S100B Kv/hEAG1 in rods Dopamine D2 Pozdnyakov et al. (1997), Rambotti et al. (1999), Duda et al.
(2002), Sahoo et al. (2010), Neve et al. (2004)
S100A10-annexin 2 Nav1.8 K2P/TASK in CFTR TRP 5, 6,
ASC1a, 5-HT1B
van de Graaf et al. (2003), Okuse et al. (2002), Foulkes et al.
(2006), Donier et al. (2005), Lotshaw (2007), Girard et al.
(2002), Renigunta et al. (2006), Svenningsson et al. (2006)
1Abbreviations: Art. memb., Artiﬁcial membrane; ASC, acid-sensing ion channel; CFTR, cystic ﬁbrosis transmembrane conductance; hEAG, human ether a go–go K+
channel; 5-HT1B, serotonin receptor; K2P, two-pore domain K+ channel; Kv, voltage gated K+ channel; Nav, voltage gated Na+ channel; RyR, ryanodine receptor; SCG,
superior cervical ganglion; SR, sarcoplasmatic reticulum; TASK, TWIK-related Acid Sensitive K+ channel; TRP transient receptor potential.
conditions (Muimo, 2009). Mutations at this protein lead to an
impairment of salt and water transport across respiratory, diges-
tive, and reproductive epithelia causing excessive mucous accu-
mulation and/or tissue ﬁbrosis. The S100A10-annexin 2 complex
is regulated in these tissues by a cyclic adenosine monophos-
phate (cAMP)/PKA/calcineurin A (CnA) – protein phosphatase
and interacts with CFTR. Inhibition of CnA disrupts complex
formation and attenuates CFTR function. Thus only the multi-
protein complex associated with S100A10-annexin 2 in its assem-
bled form is able to open CFTR Cl− channels within the cell
surface membrane (Borthwick et al., 2007, 2008). In summary,
the S100A10-annexin 2 complex is well suited for regulation of
membrane receptors and ion channels with annexin providing the
attachment to the membrane bilayer and S100A10 providing the
link to receptor, ion channel, or cytoskeletal proteins. In some cases
the binding motifs for S100A10-annexin 2 are not resolved, as in
TTX-resistant Na+ or in CFTR channels.
S100s AND LIGAND ACTIVATED CHANNELS
S100B also interacts with and modulates ligand activated channels
such as dopamine D2 metabotropic receptors (Liu et al., 2008).
Mutations at the dopaminergic system are linked to Parkinson’s
disease, schizophrenia, or drug addiction (Beaulieu and Gainetdi-
nov, 2011). The dopamine D2 receptor is a 7-TMS receptor that
acts via G-proteins Gαi and Gαo inhibiting adenylyl cyclase (AC),
K+ channels, or the mitogen-activated protein kinase (MAPK;
Neve et al., 2004). S100B appears to bind to the D2 recep-
tor’s third cytoplasmic loop at the amino acid terminus and
this way enhances receptor signaling. The third cytoplasmic loop
is also prominent as a contact site for G-protein coupling as
well as for binding of calmodulin (Liu et al., 2007). Also the
metabotropic serotonin 1B receptor (5-HT1B) has been found
to interact with S100A10-annexin 2 causing an increased local-
ization of the receptors to the plasma membrane (Svenningsson
et al., 2006). S100A10-annexin 2 was decreased during depression
attacks or depression-like states in knock-out animals but was
increased after antidepressant therapy or overexpression. Inter-
actions of S100 proteins with ion channels are summarized in
Table 1.
RELATIONSHIP TO CALMODULIN – ION CHANNEL
INTERACTIONS
It is likely that certain S100 proteins modulate the activity of
ion channels by competing with calmodulin for target binding
sites (Schäfer and Heizmann, 1996). Hence, some ion channels
that are regulated by calmodulin may in fact be modulated by
S100 proteins, either under resting conditions or under special
circumstances. Whether the effect of S100 proteins is direct or
indirect, knowledge of the molecular basis for calmodulin inter-
actions with ion channels may be helpful in discerning how S100
proteins modulate ion channels, in particular since there may well
be a similarity in their mode of action. Progress has been made
in understanding the molecular basis for calmodulin modulation
of voltage activated Ca2+ and Na2+ channels (Shah et al., 2006a).
The mechanism for Ca2+-dependent regulation of voltage gated
Na+ channels (NaV) is particularly complex, with involvement of
calmodulin, a Ca2+ binding EF-hand domain in the C-terminal
cytoplasmic domain (Wingo et al., 2004) and a calmodulin bind-
ing IQ motif just downstream the EF-hand domain (Shah et al.,
2006b). These twoCa2+ sensorsmutually inﬂuence each other and
modulate the fast inactivation gate in the D3–D4 linker domain
(Potet et al., 2009; Sarhan et al., 2009). The physiological relevance
of Ca2+ regulation of NaV channels is underscored by mutations
in the Ca2+ regulatory apparatus being associated with a variety
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of heart arrhythmia syndromes. In tetrodotoxin-insensitive Na+
channels (Nav1.8) S100A10-annexin 2 binds to the N-terminus
and promotes their translocation to the plasma membrane pro-
ducing functional channels (Okuse et al., 2002). Increased Nav1.8
activity has been proposed to cause hyperexcitability of sensory
neurons, a mechanism that renders nociceptors more sensitive.
Whether S100s also play a role in this context in genuine Na+
channels remains to be investigated.
S100 PROTEINS IN NON-VERTEBRATE ORGANISMS?
Sequence comparisons of the genomes of yeast, Caenorhabditis
elegans, and Drosophila revealed no typical S100 genes in these
species (Heizmann et al., 2002). The EF-hand CaBP family is well
conserved as the motif is even found in bacteria. The inability
to recognize S100 proteins in non-vertebrate species may arise
because the features of the invertebrate protein sequence deviate
from the basic form and therefore cannot be recognized by tra-
ditional sequence search algorithms. Also, key to identifying S100
proteins is the unique 14-amino acid, S100-speciﬁc Ca2+ binding
loop in their N-terminal binding site. These key sites may be dif-
ﬁcult to identify due to the conservation of only the Glu residue
in position 14. Although the S100-speciﬁc loop is unique, it is in
fact not the most distinguishing characteristic of S100 proteins.
Rather, it is their integrated dimeric structural unit that makes
S100 proteins different from all other EF-hand CaBPs. Since there
is no current method to recognize dimeric proteins based on pro-
tein sequence, one cannot completely rule out that S100 proteins
are not present in non-vertebrate organisms.
This line of reasoning also suggests that the use of vertebrate
S100 antibodies to identify S100 in invertebrates is questionable.
The antibodies to invertebrate S100proteinsmayneed to recognize
a different epitope that has no sequence resemblance to vertebrate
S100 proteins. Further studies are necessary to obtain and analyze
more sequence and structural information from a range of species
to investigate the evolution of this protein family in more detail
(Heizmann et al., 2002), and to possibly identify the presence or
absence of a S100-like protein in invertebrates. Even if S100-like
CaBPs can not be recognized in invertebrates, S100 proteins can
clearly affect their electrical discharge activity and alter membrane
conductances. Thus, S100 proteins from a vertebrate host have the
potential to interact with binding sites on channels or to modulate
intracellular signaling to an extent that channel gating is affected
in an invading non-vertebrate organism.
CONCLUDING REMARKS
S100 EF-hand proteins exhibit a remarkably diverse range of cel-
lular functions. Accumulating evidence indicates that they can
modulate the activities of ion channels. We hypothesize that var-
ious ion channels, in particular K+ channels, exhibit intracellular
binding sites for several S100 proteins, which serve as Ca2+ sensor
to modulate their electrical behavior. These binding sites may cor-
respond to known sites for the ubiquitous EF-hand Ca2+ sensor
calmodulin, but might also be distinct. The potential for over-
lap complicates efforts to assign speciﬁc biological functions to
S100 proteins. Given the differences in the structural basis for tar-
get activation by monomeric calmodulin versus oligomeric S100
proteins, it is conceivable that the effects of S100 proteins will be
distinct from those of calmodulin. Further biochemical, structural,
and functional studies are required to elucidate the physiological
role(s) of S100 protein inmodulating the function of ion channels.
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